Lance Alstodt, President, CEO, COB at BioRestorative Therapies, Inc. (BRTX), bought 2,700 shares at $3.52 ($10K) on 2022-05-26, disclosed to the SEC on 2022-05-27.
Open-market purchase of $10k BRTX by President, CEO, COB. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| BRTX | BUY | 2023-09-06 | $6K | — | Filing → |
| BRTX | BUY | 2023-07-25 | $10K | — | Filing → |
| BRTX | BUY | 2023-02-02 | $1K | — | Filing → |